Ballentine Partners LLC Buys 975 Shares of Aflac Incorporated (NYSE:AFL)

Ballentine Partners LLC raised its stake in shares of Aflac Incorporated (NYSE:AFLFree Report) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,282 shares of the financial services provider’s stock after acquiring an additional 975 shares during the period. Ballentine Partners LLC’s holdings in Aflac were worth $2,603,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its stake in Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after acquiring an additional 285,576 shares in the last quarter. APG Asset Management N.V. raised its stake in shares of Aflac by 1.3% during the 2nd quarter. APG Asset Management N.V. now owns 2,429,316 shares of the financial services provider’s stock worth $202,437,000 after purchasing an additional 31,752 shares during the period. Guinness Asset Management LTD raised its stake in shares of Aflac by 3.8% during the 3rd quarter. Guinness Asset Management LTD now owns 2,276,325 shares of the financial services provider’s stock worth $254,382,000 after purchasing an additional 83,289 shares during the period. ProShare Advisors LLC raised its stake in shares of Aflac by 5.6% during the 2nd quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock worth $198,279,000 after purchasing an additional 117,504 shares during the period. Finally, Truist Financial Corp raised its stake in shares of Aflac by 26.6% during the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock worth $172,338,000 after purchasing an additional 405,847 shares during the period. 67.44% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AFL has been the topic of a number of recent analyst reports. Jefferies Financial Group lowered their target price on Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Wells Fargo & Company lifted their target price on Aflac from $90.00 to $106.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 10th. TD Cowen initiated coverage on Aflac in a research note on Wednesday, October 9th. They set a “hold” rating and a $102.00 target price on the stock. Evercore ISI lifted their target price on Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a research note on Thursday, September 26th. Finally, Bank of America boosted their price objective on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $97.53.

Get Our Latest Research Report on AFL

Aflac Stock Down 2.1 %

Shares of NYSE AFL opened at $109.69 on Friday. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $62.33 billion, a price-to-earnings ratio of 12.11, a PEG ratio of 2.62 and a beta of 0.95. The business has a 50-day moving average of $110.22 and a 200-day moving average of $96.59.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping the consensus estimate of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $4.10 billion. During the same quarter in the previous year, the firm earned $1.58 earnings per share. Aflac’s revenue was down .7% on a year-over-year basis. Sell-side analysts expect that Aflac Incorporated will post 6.76 earnings per share for the current fiscal year.

Aflac Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.82%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s payout ratio is 22.08%.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the transaction, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.90% of the stock is owned by insiders.

Aflac Company Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Recommended Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.